Scientific Resources
Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.
Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.
Found 55 Results
Ultrasensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage non-small cell lung cancer (NSCLC).
June 5, 2024 | Poster
MRD Testing: Finding Common Ground
May 3, 2024 | Blog Post
Toward a cure for cHL without chemotherapy
February 29, 2024 | Article
Early and sustained ctDNA response in lonca for 3L DLBCL – Dr. David Kurtz, ASH 2023
February 6, 2024 | Video
Prospective real-world study on the utility of PhasED-Seq MRD – Dr. Brian Sworder, ASH 2023
January 31, 2024 | Video
Optimizing ctDNA limits of detection for DLBCL during 1L therapy – Dr. Jordan Goldstein, ASH 2023
January 31, 2024 | Video